Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DarioHealth Corp. - Common Stock (NQ:DRIO)

7.250 +0.880 (+13.81%)
Streaming Delayed Price Updated: 10:12 AM EDT, Apr 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DarioHealth Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Present Research Regarding Digital Solution on Depression, Anxiety at APA Convention
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Multi-Chronic Contract with National Employer for Full-Solution Suite
Via Investor Brand Network
News headline image
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market ↗
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and... 
Via Benzinga
News headline image
Recap: DarioHealth Q1 Earnings ↗
DarioHealth (NASDAQ:DRIO) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Recap: DarioHealth Q4 Earnings ↗
DarioHealth (NASDAQ:DRIO) reported its Q4 earnings results on Tuesday, March 22, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
DarioHealth Earnings Preview ↗
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Contract with National Employer
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Solera Health for Added Hypertension Management Solutions
Via Investor Brand Network
News headline image
DarioHealth Earnings Perspective: Return On Capital Employed ↗
According to data from Benzinga Pro, during Q1, DarioHealth's (NASDAQ:DRIO) reported sales totaled $8.06 million. Despite a 26.27% increase in earnings, the company posted a loss of $15.92 million. 
Via Benzinga
News headline image
Dario Health (DRIO) Poised To Inflect Upon Full Launch of National Health Plan Rumored To Be Aetna (AET) ↗
Dario Health (DRIO) Poised to Inflect Upon Full Launch of National Health Plan Rumored to be Aetna (AET) - Fundamentals: Company positioned to avoid dilutive financing after... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with OrbiMed to Close on $50 Million Credit Facility
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presenting Key Findings from Three New Studies at ADA Scientific Sessions
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Commercial Contracts as Market Develops Appreciation for Integrated Digital Solutions
Via Investor Brand Network
News headline image
Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know ↗
Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
90 Biggest Movers From Yesterday ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
News headline image
58 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Record Quarterly Revenues in Q1 2022
Via Investor Brand Network
News headline image
Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY) ↗
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space... 
Via Benzinga
News headline image
Earnings Outlook For DarioHealth ↗
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q1 2022 Results, Conference Call
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research Supporting ‘Digital Solutions That Prioritize a Whole Health Experience’
Via Investor Brand Network
News headline image
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels ↗
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Solutions for Health Plan Colorado Access
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Additional Employer Contracts
Via Investor Brand Network
News headline image
DarioHealth's Return On Capital Employed Overview ↗
According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21.... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q4, Full-Year 2021 Financial Report, Operational Update
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million. 
Via Benzinga
News headline image
Earnings Scheduled For March 21, 2022 ↗
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
News headline image
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.